The MHRA will conduct its own independent benefit-risk assessment before any licence could be granted
If you've ever been diagnosed with Leber's hereditary optic neuropathy or any kidney condition
The ability to return to activities abandoned due to chronic pain, improved quality of life, and sustained relief rather than temporary symptom reduction characterize successful long-term protocols
The regulatory nod is the first new frontline treatment for patients whose cancer is mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) in decades, according to GSK
Fogaa, M.V., Fukumoto, K., Franklin, T
Recent studies of peptide-bound, active, Gs-coupled, structures of CTR or AMYRs provide evidence supporting distinct conformations of receptors when bound to CT peptides versus amylin peptides 15 that may contribute to pharmacological differences between dual CTR and AMYR agonists